Glyceollins from soybean: Their pharmacological effects and biosynthetic pathways

• Published in: Heliyon Vol. 9; no. 11; p. e21874
• Main Authors: Yue, Zhiyong, He, Shanhong, Wang, Jinpei, Jiang, Qi, Wang, Hanping, Wu, Jia, Li, Chenxi, Wang, Zixian, He, Xuan, Jia, Nannan
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01-11-2023; Elsevier
• Subjects: Angiogenesis; Biosynthesis; Breast cancer; Glyceollins; Isoflavonoids; Review; Soybean; Angiogenesis; Isoflavonoids; Breast cancer; Biosynthesis; Soybean; Glyceollins
• ISSN: 2405-8440; 2405-8440
• DOI: 10.1016/j.heliyon.2023.e21874

Flavonoids are a highly abundant class of secondary metabolites present in plants. Isoflavonoids, in particular, are primarily synthesized in leguminous plants within the subfamily Papilionoideae. Numerous reports have established the favorable role of isoflavonoids in preventing a range of human diseases. Among the isoflavonoid components, glyceollins are synthesized specifically in soybean plants and have displayed promising effects in mitigating the occurrence and progression of breast and ovarian cancers as well as other diseases. Consequently, glyceollins have become a sought-after natural component for promoting women's health. In recent years, extensive research has focused on investigating the molecular mechanism underlying the preventative properties of glyceollins against various diseases. Substantial progress has also been made toward elucidating the biosynthetic pathway of glyceollins and exploring potential regulatory factors. Herein, we provide a review of the research conducted on glyceollins since their discovery five decades ago (1972–2023). We summarize their pharmacological effects, biosynthetic pathways, and advancements in chemical synthesis to enhance our understanding of the molecular mechanisms of their function and the genes involved in their biosynthetic pathway. Such knowledge may facilitate improved glyceollin synthesis and the creation of health products based on glyceollins.